Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trevena Inc.

www.trevenainc.com

Latest From Trevena Inc.

Keeping Track: US FDA Approves Sanofi’s Dengvaxia, But Heron’s HTX-011 And Nabriva’s Contepo Fall Short

The latest drug development news and highlights from our US FDA Performance Tracker.
Approvals Drug Review

FDA Finalizes Comparative Safety, Efficacy Requirement For New Opioids

New opioids will need to provide a “significant advantage” over approved products under new requirements that treat opioids “differently” from other drug classes, outgoing Commissioner Gottlieb says.
Neurology Drug Review

Breakthrough Designation Rescissions: Who Might US FDA Drop Next?

Our chart details the pipeline candidates who might lose the coveted status as treatment paradigms change and trial results come in.
Review Pathway Drug Review

Breaking Up With Breakthrough: Trevena And Tonix Lose Designation, But Continue With Pivotal Plans

US FDA rescinds breakthrough designations for Tonix’ PTSD therapy Tonyma and Trevena’s novel pain drug Olinvo after clinical trial disappointments – and after identifying other regulatory pathways to market.
Review Pathway Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Trevena Inc.
  • Senior Management
  • Maxine Gowen, PhD, Pres. & CEO
    David P. P Geoghegan, SVP, Operations
    Jonathan Violin, PhD, SVP, Scientific Affairs & IR Officer
    Carrie L Bourdow, EVP, COO
    Michael Catalano, VP, Mktg.
    Bob Yoder, VP, Sales & Commercial Ops.
  • Contact Info
  • Trevena Inc.
    Phone: (610) 354-8840
    955 Chesterbrook Blvd.
    Ste. 200
    Chesterbrook, PA 19087
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register